Park West Asset Management LLC Has $36.90 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Park West Asset Management LLC has reduced its stake in UnitedHealth Group by 6.2%, owning 70,450 shares valued at approximately $36.9 million as of its latest SEC filing.
• In the first quarter, several institutional investors significantly increased their positions in UnitedHealth Group, with Bayforest Capital Ltd's holdings jumping by 685.7%.
• UnitedHealth Group's stock has a consensus rating of "Moderate Buy" from analysts, with a current price target of $354.86.

Park West Asset Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 70,450 shares of the healthcare conglomerate's stock after selling 4,650 shares during the quarter. UnitedHealth Group accounts for approximately 3.0% of Park West Asset Management LLC's portfolio, making the stock its 14th largest holding. Park West Asset Management LLC's holdings in UnitedHealth Group were worth $36,898,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Financial Management Professionals Inc. lifted its position in UnitedHealth Group by 0.8% in the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after purchasing an additional 17 shares during the last quarter. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares during the last quarter. Kolinsky Wealth Management LLC lifted its position in UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock valued at $1,080,000 after purchasing an additional 21 shares during the last quarter. Retirement Planning Group LLC lifted its position in UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after purchasing an additional 21 shares during the last quarter. Finally, Net Worth Advisory Group lifted its position in UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.5%

Shares of UnitedHealth Group stock traded up $4.72 during trading on Friday, hitting $315.10. The stock had a trading volume of 14,093,579 shares, compared to its average volume of 17,228,082. The stock has a 50 day simple moving average of $288.78 and a 200 day simple moving average of $372.56. The company has a market capitalization of $285.38 billion, a PE ratio of 13.65, a P/E/G ratio of 2.04 and a beta of 0.44. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue was up 12.9% on a year-over-year basis. During the same period last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Hsbc Global Res downgraded shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Piper Sandler dropped their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. HSBC restated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Finally, Barclays boosted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research report on Thursday. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $354.86.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.28% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.